Matthew K. Szot - SEC Form 4 Insider Trading Activity
Summary
Updated Aug 3, 2026
Matthew K. Szot has filed 1 SEC Form 4 filing across 1 company in the last 90 days - selling. Lifetime open-market sales: $397K.
Profile
Matthew K. Szot serves as Director of SenesTech, Inc. (SNES). Szot has also held reporting roles at Cadrenal Therapeutics, Inc. (CVKD) and INVO Fertility, Inc. (IVF). Szot has reported 16 insider filings with the SEC since 2025. The most recent filing was in June 2026.
| Role | Director |
|---|---|
| Notability | 34/100 |
Board memberships
- SenesTech, Inc.
- Cadrenal Therapeutics, Inc.
- INVO Fertility, Inc.
Reported roles
- Director
- Chief Financial Officer
- Director
Awards & honors
- Chief Financial Officer at INVO Fertility
- Director at multiple companies
- Involved in assisted reproductive technology
Trading Pattern
InsiderAlpha's records for Matthew K. Szot go back to 2025: 11 primary Form 4 filings, an average of 5.5 per year. 6 recorded transactions carry a Rule 10b5-1 flag, meaning they were pre-scheduled under a written trading plan rather than discretionary.
Career & Filing History
Every role Matthew K. Szot has reported on a Form 4, reconstructed from the filings themselves - reporting insiders must state their relationship to the issuer (officer title, director seat, or 10% ownership) on every filing.
- Director at SenesTech, Inc. (SNES) - 2 filings, 2025 to 2026
- Chief Financial Officer at Cadrenal Therapeutics, Inc. (CVKD) - 7 filings, 2025
- Director at INVO Fertility, Inc. (IVF) - 2 filings, 2025
Recent Transactions
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale [10b5-1] | 9.9K | $6.97 | $69K |
| 2025-12-05 | IVF | INVO Fertility, Inc. | J - Other acquisition / disposition | 3 | $0.00 | |
| 2025-12-05 | IVF | INVO Fertility, Inc. | S - Open-market sale | 4 | $1.52 | $6 |
| 2025-11-17 | SNES | SenesTech, Inc. | S - Open-market sale | 1 | $2.75 | $3 |
| 2025-10-28 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale [10b5-1] | 1.8K | $13.99 | $25K |
| 2025-10-28 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale [10b5-1] | 1.8K | $13.99 | $25K |
| 2025-10-14 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale [10b5-1] | 1.8K | $14.07 | $25K |
| 2025-10-14 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale [10b5-1] | 1.7K | $13.99 | $24K |
| 2025-10-06 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale [10b5-1] | 107 | $13.99 | $1K |
| 2025-09-29 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale | 1.7K | $13.99 | $24K |
| 2025-09-29 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale | 100 | $14.00 | $1K |
| 2025-09-24 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale | 10.9K | $14.05 | $153K |
| 2025-09-24 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale | 1.5K | $14.00 | $21K |
| 2025-08-27 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale | 400 | $14.00 | $6K |
| 2025-08-27 | CVKD | Cadrenal Therapeutics, Inc. | S - Open-market sale | 1.6K | $13.99 | $22K |
Companies - Last 90 Days
- SenesTech, Inc. (SNES) - 1 filing, last 2026-06-17
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades at the companies Matthew K. Szot has recently filed at. Multiple unrelated insiders buying the same stock within a short window - cluster buying - has historically been one of the strongest Form 4 signals.
- GLENBROOK CAPITAL MANAGEMENT - $958K of SNES open-market activity in the last 12 months
- Michael Edell - $8K of SNES open-market activity in the last 12 months
- Jacob Steven Leach - $168 of SNES open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
- Neil Mehta
- Keith A. Meister
- MetLife Investment Management, LLC
- John Micek
- Andrew J. Mills
- Charles N. Mills
- Kevin J. Mills
- Mink Brook Asset Management LLC
Frequently Asked Questions
Who is Matthew K. Szot?
Matthew K. Szot serves as Director of SenesTech, Inc. (SNES). Szot has also held reporting roles at Cadrenal Therapeutics, Inc. (CVKD) and INVO Fertility, Inc. (IVF). Szot has reported 16 insider filings with the SEC since 2025. The most recent filing was in June 2026.…
How many SEC Form 4 filings has Matthew K. Szot submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Matthew K. Szot been buying or selling stock?
Recorded transactions: 0 open-market purchases and 14 open-market sales ($397K) across all tracked filings.
Where can I see all of Matthew K. Szot's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Open the live Matthew K. Szot profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.